🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Helicobacter pylori (H. pylori), which infects about 50% of the global popu...
Status
Unknown
Location
Multiple Locations
Start Date
2017-05-30
Trial ID
NCT03139253
Treatments Being Tested
Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Status
Completed
Location
Peking University Third Hospital
Start Date
2005-09
Trial ID
NCT00952978
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of 8 weeks o...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00471094
Treatments Being Tested
Ilaprazole is a novel proton pump inhibitor and metabolized by CYP3A4 and 2...
Status
Completed
Location
Inje University Busan Paik Hoapital Clinical Trial Center
Start Date
2009-01
Trial ID
NCT01688544
Treatments Being Tested
This study is designed to evaluate the efficacy and tolerability of ilapraz...
Status
Unknown
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01107938
Treatments Being Tested
Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT02847455
Treatments Being Tested
Helicobacter pylori (H. pylori), which infects about 50% of the global popu...
Status
Unknown
Location
Department of Gastroenterology, Qilu Hospital, Shandong University
Start Date
2017-04-20
Trial ID
NCT02988089
Treatments Being Tested
Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Status
Completed
Location
Peking University Third Hospital
Start Date
2004-10
Trial ID
NCT00953381
Treatments Being Tested
This study evaluate the pharmacokinetic drug interaction in Ilaprazole, Cla...
Status
Completed
Location
Severance Hospital
Start Date
2016-12
Trial ID
NCT02998437
Treatments Being Tested
This study is designed to evaluate the efficacy and tolerability of ilapraz...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT02860624
Treatments Being Tested